TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Curcumin, Binimetinib
Phytochemical Name Curcumin (PubChem CID: 969516 )
Anticancer drug Name Binimetinib (PubChem CID: 10288191 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 403
Pair Name Curcumin, Binimetinib
Disease Info [ICD-11: 2C30] Melanoma Investigative
Biological Phenomena Induction-->Necroptosis
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Cleavage CASP3 hsa836
Down-regulation Expression MCL1 hsa4170
Up-regulation Phosphorylation MLKL hsa197259
Up-regulation Phosphorylation RIPK3 hsa11035
Up-regulation Expression TP53 hsa7157
In Vitro Model G361 Glioblastoma Homo sapiens (Human) CVCL_C8ZL
SK-MEL-2 Melanoma Homo sapiens (Human) CVCL_0069
Result Our data demonstrates that curcumin exerts significant synergistic anticancer effects on MM cells by inducing ROS and necroptosis when combined with binimetinib. Therefore, a strategy of adding curcumin to conventional anticancer agents holds promise for treating MM.
03. Reference
No. Title Href
1 Curcumin Enhances the Anticancer Effects of Binimetinib on Melanoma Cells by Inducing Mitochondrial Dysfunction and Cell Apoptosis with Necroptosis. Ann Dermatol. 2023 Jun;35(3):217-228. doi: 10.5021/ad.22.200. Click
It has been 48403 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP